X-ray and radiation therapy technology developer Xstrahl has signed a deal with C&C Irradiator Service of Washington, DC, to supply x-ray irradiator systems that will replace cesium sources across the U.S.
Cesium-137 is used in older radiotherapy systems and irradiators but can be dangerous and difficult to dispose of safely, the company said. Under terms of the deal, Xstrahl will provide C&C with services that include decommissioning existing gamma irradiators and transitioning to x-ray irradiators, according to the firm.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
